Attached files
| file | filename |
|---|---|
| EX-99.1 - HNO International, Inc. | v238694_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 31, 2011
Clenergen Corporation
(Exact name of registrant as specified in its charter)
| Nevada | 333-130286 | 20-2781289 |
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
3753 Howard Hughes Parkway
Suite 200, Las Vegas NV 89169
|
||
| Not applicable
(Address of principal executive offices)
|
(Zip Code) |
Registrant’s telephone number, including area code: +1 702 784 5921
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Introductory Comment - Use of Terminology
Throughout this Current Report on Form 8-K, the terms “we,” “us” and “our” refers to the registrant, Clenergen Corporation, and, where applicable, its wholly-owned subsidiaries, on a consolidated basis.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Mike Starkie submitted his resignation as the Non Executive Chairman and Acting Chief Financial Officer and as a director of our company on October 16, 2011. Mr. Starkie noted in his resignation letter that he was submitting his resignation for reasons other than those requiring further disclosure under paragraph (a)(1) of Item 5.02 of Form 8-K.
Item 9.01 Financial Statement and Exhibits.
The following exhibits are being filed as part of this Current Report on Form 8-K.
|
Exhibit
Number
|
Exhibit Description |
|
99.1
|
Resignation letter dated October 16, 2011, of Mike Starkie.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: October 31, 2011 |
Clenergen Corporation
|
||
|
|
By:
|
||
|
Mark Quinn
Chief Executive Officer
|
|||